CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates

CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.37 per share versus the Zacks Consensus Estimate of a loss of $1.15. This compares to a loss of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.85%. A quarter ago, it was expected that this company would post a loss of $1.32 per share when it actually produced a loss of $1.17, delivering a surprise of +11.36%.Over the last four quarters, the company h ...